No Data
No Data
SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?
Here Are J. P. Morgan's Top MedTech Picks for 2025
U.S. Healthcare Execs Turn More Bullish for 2025: Deloitte
Wall Street Posts Weekly Loss as It Transitions Into New Year After Banner 2024
Novo Nordisk Seeks to Block Compounded Victoza
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz